Association of Heart Failure with Preserved Ejection Fraction and Components of Metabolic Syndrome

1. Zile MR, Brutsaert DL. New concepts in diastolic dysfunction and diastolic heart failure: part I: diagnosis, prognosis, and measurements of diastolic function. Circulation. 2002;105:1387e93.10.1161/hc1102.105289Search in Google Scholar

2. Bonow RO, Udelson JE. Left ventricular diastolic dysfunction as a cause of congestive heart failure. Mechanisms and management. Ann Intern Med. 1992;117:502–510.10.7326/0003-4819-117-6-502Search in Google Scholar

3. Vasan RS, Benjamin EJ, Levy D. Prevalence, clinical features and prognosis of diastolic heart failure: an epidemiologic perspective. J Am Coll Cardiol. 1995;26:1565–1574.10.1016/0735-1097(95)00381-9Search in Google Scholar

4. Penjašković D, Sakač D, Dejanović J et al. Left ventricular diastolic dysfunction in patients with metabolic syndrome. Med Pregl. 2012;65(1-2):18-22.10.2298/MPNS1202018PSearch in Google Scholar

5. Senni M, Redfield MM. Heart failure with preserved systolic function. A different natural history? J Am Coll Cardiol. 2001;38:1277–1282.10.1016/S0735-1097(01)01567-4Search in Google Scholar

6. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). Final report. Circulation. 2002;106:3143–3421.10.1161/circ.106.25.3143Search in Google Scholar

7. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome: a new world-wide definition. Diabet Med. 2006;23(5):469-480.10.1111/j.1464-5491.2006.01858.x16681555Search in Google Scholar

8. Grundy SM, Pasternak R, Greenland P et al. Assessment of Cardiovascular Risk by Use of Multiple-Risk-Factor Assessment Equations. Circulation. 1999;100:1481-1492.10.1161/01.CIR.100.13.1481Search in Google Scholar

9. William C. Little, Jae K. Oh. Controversies in Cardiovascular Medicine. Echocardiographic Evaluation of Diastolic Function Can Be Used to Guide Clinical Care. Circulation. 2009;120:802-809.10.1161/CIRCULATIONAHA.109.86960219720946Search in Google Scholar

10. Mancia G, Fagard R, Narkiewicz K et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension. The Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European Heart Journal. 2013;34:2159–2219.10.1093/eurheartj/eht15123771844Search in Google Scholar

11. Jousilahti P, Vartiainen E, Tuomilehto J et al. Sex, Age, Cardiovascular Risk Factors, and Coronary Heart Disease. A Prospective Follow-Up Study of 14 786 Middle-Aged Men and Women in Finland. Circulation. 1999;99:1165-1172.10.1161/01.CIR.99.9.1165Search in Google Scholar

12. Ayalon N, Gopal DM, Mooney DM et al. Preclinical left ventricular diastolic dysfunction in metabolic syndrome. Am J Cardiol. 2014;114(6):838-842.10.1016/j.amjcard.2014.06.013416274625084691Search in Google Scholar

13. Rashid Khan A, Qaisar Khan M. Association and pattern of diastolic dysfunction in patients of metabolic syndrome. J Ayub Med Coll Abbottabad. 2008;20(2):70-75.Search in Google Scholar

14. Aksoy S, Durmus G, Ozcan S et al. Is left ventricular diastolic dysfunction independent from presence of hypertension in metabolic syndrome? An echocardiographic study. J of cardiol. 2014;64(3):194-198.10.1016/j.jjcc.2014.01.00224525047Search in Google Scholar